Savencia (BGJ) Price & Analysis

0 Followers

BGJ Stock Chart & Stats

€61.60

€0.40(0.79%)

At close: Jan 08 4:00 PM EST

€61.60

€0.40(0.79%)

Day’s Range― - ―

52-Week Range€56.60 - €73.60

Previous CloseN/A

Volume50.00

Average Volume (3M)11.00

Market Cap

€781.76M

Enterprise Value€2.09K

Total Cash (Recent Filing)€684.84M

Total Debt (Recent Filing)€1.24B

Price to Earnings (P/E)10.3

Beta0.24

Next Earnings

Mar 11, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)5.73

Shares Outstanding14,032,930

10 Day Avg. Volume0

30 Day Avg. Volume11

Financial Highlights & Ratios

PEG Ratio-0.38

Price to Book (P/B)0.52

Price to Sales (P/S)0.13

P/FCF Ratio14.73

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)10.52

Revenue Forecast (FY)€7.77B

Bulls Say, Bears Say

Bulls Say

Diversified Dairy PortfolioA broad mix of branded consumer products and specialty dairy offerings gives Savencia several routes to market and reduces reliance on a single product type. Serving both retail and foodservice customers can support resilience across demand channels and sustain relevance over the next several quarters.

International Market ReachOperations across multiple international markets provide geographic diversification and access to varied customer demand. This reach can support the company’s long-term scale, broaden opportunities for branded and specialty products, and reduce dependence on conditions in one national market.

Manageable LeverageDebt-to-equity of about 0.74 indicates leverage is described as manageable for a packaged foods business, while relatively stable equity provides a degree of balance-sheet support. This should preserve more financial flexibility than a highly leveraged structure if earnings remain pressured.

Bears Say

Revenue ContractionThe 2025 revenue decline interrupts the prior pattern of growth from 2020 through 2024 and indicates weaker recent demand, mix, or pricing outcomes. Sustained top-line pressure would limit operating leverage, reduce reinvestment capacity, and make recovery dependent on renewed sales growth.

Thin And Declining ProfitabilityA net margin near 1.1% leaves limited protection against further cost pressure or weaker volumes. The simultaneous compression in EBIT and EBITDA margins suggests reduced operating leverage and makes earnings more sensitive to changes in pricing, product mix, and operating costs.

Weak Cash ConversionPositive cash generation is weakened by lower operating cash flow and sharply reduced free cash flow. Coverage of only about 19% of net income limits internally generated funding for debt reduction, dividends, and reinvestment, reducing flexibility if operating performance stays soft.

Savencia News

Savencia’s Half-Year Results Show Acquisition-Driven Growth Amid Margin and Debt Pressures

The latest update is out from Savencia ( ($FR:SAVE) ). Savencia reported first-half 2026 sales of €3.486 billion,...

7d ago

Savencia Updates Share Capital and Voting Rights as of July 2026

Savencia ( ($FR:SAVE) ) has provided an update. Savencia reported that as of July 31, 2026, its share...

1M ago

Savencia (0DTK) Reveals Q2 Dividend: Here’s the Essential Information

Savencia (LSE: 0DTK) has declared, under its dividend policy, a yearly cash dividend in the amount of €1.60...

1y ago

Savencia (0DTK) Announces Q2 Dividend: Save the Dates!

Savencia (LSE: 0DTK) has declared, under its dividend policy, a yearly cash dividend in the amount of €1.40...

2y ago

BGJ FAQ

What was Savencia SA’s price range in the past 12 months?

Savencia SA lowest stock price was €56.60 and its highest was €73.60 in the past 12 months.

What is Savencia SA’s market cap?

Savencia SA’s market cap is €781.76M.

When is Savencia SA’s upcoming earnings report date?

Savencia SA’s upcoming earnings report date is Mar 11, 2027 which is in 175 days.

How were Savencia SA’s earnings last quarter?

Savencia SA released its earnings results on Sep 10, 2026. The company reported €2.913 earnings per share for the quarter.

Is Savencia SA overvalued?

According to Wall Street analysts Savencia SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Savencia SA pay dividends?

Savencia SA does not currently pay dividends.

What is Savencia SA’s EPS estimate?

Savencia SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Savencia SA have?

Savencia SA has 14,032,930 shares outstanding.

What happened to Savencia SA’s price movement after its last earnings report?

Savencia SA reported an EPS of €2.913 in its last earnings report. Following the earnings report the stock price went up 0.325%.

Which hedge fund is a major shareholder of Savencia SA?

Currently, no hedge funds are holding shares in DE:BGJ

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Savencia SA

Savencia SA is a French-headquartered enterprise, established in 1956, specializing in the production of dairy items for both domestic and international markets. The company's product portfolio encompasses a diverse range of cheeses, along with butters and creams supplied to consumer retail outlets and professional catering services. Additionally, it furnishes dairy ingredients for the food, nutrition, and healthcare sectors. Known as Bongrain SA until its rebranding in April 2015, the firm now operates under the name Savencia SA and is based in Viroflay, France.